HudaSalmanMD

Hematology • Indianapolis, IN

Hematologic Oncology

Associate Professor, Internal Medicine, Stony Brook University School of Medicine

Join to view full profile

Dr. Salman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Salman's full profile

Already have an account?

Office
Brown center Indiana University
Indianapolis, IN 46202

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1999 - 2002
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1996 - 1999
University of Jordan Faculty of MedicineClass of 1991

Certifications & Licensure

IN State Medical License 2021 - 2025
NY State Medical License 2015 - 2022
GA State Medical License 2013 - 2016
VA State Medical License 2011 - 2014
OH State Medical License 2009 - 2012
TN State Medical License 2005 - 2007
American Board of Internal Medicine Hematology

Clinical Trials

CD4CAR for CD4+ Leukemia and Lymphoma Start of enrollment: 2020 Jul 09
Recruiting
Phase 1
Roles: Study Chair, Contact, Sponsor-Investigator, Principal Investigator
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML. Start of enrollment: 2024 Feb 21
Recruiting
Phase 1
Roles: Principal Investigator, Sponsor-Investigator, Contact
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant Start of enrollment: 2024 Mar 19
Recruiting
Phase 1
Roles: Principal Investigator, Sponsor-Investigator, Contact

Publications & Presentations

PubMed

51 citations
Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Do...
Elliott Bennett-Guerrero, Jamie L. Romeiser, Lillian R Talbot, Tahmeena Ahmed, Linda J Mamone
Critical Care Medicine. 2021-07-01
29 citations
Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells.
Huda S. Salman, Kevin G. Pinz, Masayuki Wada, Xiao Shuai, Lulu E. Yan
Journal of Cancer. 2019-07-23
80 citations
Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells.
Kevin G. Pinz, Elizabeth Yakaboski, Alexander Jares, Hua Liu, Amelia E. Firor
Oncotarget. 2017-11-22